摘要:
The present invention relates to a pharmaceutical compositions which comprises bioactive somatotropin and at least two kinds of lipid-soluble vitamins, and more particularly to a parenterally administered pharmaceutical composition which can solve inconvenience of administering somatotropin and lipid-soluble vitamins respectively and which shows the sustained effect of somatotropin and the synergic effect of somatotropin and lipid-soluble vitamins.
摘要:
An apparatus capable of providing location-based data includes a communication unit to transmit data to a server and to receive base location-based data from the server via a communication network, a display unit to display the base location-based data, and a control unit to control the display unit to further display synthesized data including first user location-based data and the base location-based data. A method for providing location-based data includes acquiring user location-based data including location information, acquiring base location-based data including location information, and synthesizing the user location-based data into corresponding region of the base location-based data.
摘要:
The present invention relates to an improved somatotropin composition consisting of somatotropin having in vivo, at least one of lipid-soluble vitamins and at least one of pharmaceutically acceptable lubricants, which improves poor syringeability under cold temperature which has been a defect of the conventional somatotropin formulation using vitamins, and which shows at least the equivalent effect to that of the conventional formulation.
摘要:
The present invention relates to a sustained-release formulation of an animal growth hormone and a process for preparation thereof, comprising a step to produce solid pellets by mixing an animal growth hormone and an excipient in accordance with a direct tabletting method and a step to coat the pellets with a film comprising a biodegradable polymer and a poloxamer. The thus obtained formulation has small initial drug release, and shows a continuous and uniform effect when administered. Further, the formulation of the present invention may be produced economically in a large scale.
摘要:
The present invention relates to a release-controlled implantable composition comprising somatotropin, a bio-compatible wax and a water-soluble polymer. The present composition exhibits superior sustained effect with little side effects, which renders it suitable for long-term administration.